Health Reform

197 Groups Urge HHS to Prevent Discrimination against Patients in ACA Plans

197 organizations that are part of the I Am Essential coalition urged Health and Human Services (HHS) Secretary Sylvia Burwell to better define and address discriminatory insurance benefit design in the final rule to implement Sec. 1557 of the Affordable Care Act (ACA), which is charged with protecting beneficiaries against discrimination in health programs.

Obama Administration Guidance Will Increase Access to Hepatitis C Cure Drugs

The AIDS Institute praises the Obama Administration for their letter to State Medicaid Directors that suggests states lift their onerous restrictions that have prevented people living with hepatitis C access to medications that can cure them. 

Sign-on Letter Urging HHS to Define ACA Discrimination

The “I Am Essential” coalition, representing hundreds of patient groups and their allies, has prepared comments on the U.S.

Hepatitis B & C Drugs Difficult to Access in Florida's Health Plans

The AIDS Institute's analysis of Florida’s Silver 2015 qualified plans reveals that discriminatory plan design is much more widespread for people accessing hepatitis B and C drugs than HIV drugs.

Support for Maximum Out-of-Pocket Cost-Sharing Limits

Below is a letter from the I Am Still Essential coalition urging strong support of CCIIO’s enforcement of the ACA requirements on maximum out-of-pocket limits for cost-sharing for plan year 2016.

CCIIO Responds to I Am (Still) Essential Coalition's Letter Urging Review for 2016 Plans

Head of CCIIO, Kevin Counihan assures patient groups the federal government will adequately review 2016 qualified health plans. 

Syndicate content